We are pleased to announce that our applications for the higher dose regimen of nusinersen are now under review in the US and Europe,” said Stephanie Fradette, Pharm.D., Head of the Neuromuscular ...

That brings the total to 25 drugs that will have lower price tags under a historic new program that allows the government to haggle over the price Medicare pays on the most popular and expensive ...

January 17, 2025--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has accepted the New Drug Application ...

The savings on the 25 drugs stem from a new law that allows Medicare to haggle over the price it pays on the most popular and expensive prescription drug scripts filled by older Americans.

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price negotiations, federal health officials announced Friday. The negotiations for ...

While the resulting product, Pluvicto, has already been approved by the US Food and Drug Administration (FDA), the new study, if successful ... the FDA accepted it and Daiichi Sankyo’s joint ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Please provide your email address to receive an email when new articles are posted on ... episodes and nighttime blood pressure (BP). The drug’s safety profile in this specific patient ...

Today, the Governments of Canada and the province of New Brunswick signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $32 million over three years to improve access ...

Their 'Malteser-like' molecules could one day have a suite of applications ... of making these new nanoscale spheres that may one day be used, for example, in the future of drug delivery ...

The application was refiled following a December 20, 2024, meeting between the US Food and Drug Administration (FDA) and Astellas. The US Food and Drug Administration (FDA) has accepted the revised ...